Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery

This study has been completed.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Sonia Yoo, Bascom Palmer Eye Institute
ClinicalTrials.gov Identifier:
NCT00769145
First received: October 7, 2008
Last updated: July 24, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)